Treatment with CTLA4-Ig inhibits rejection of liver allografts from Flt3-ligand-treated donors

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 453-

  Fu, F ^a   Li, W ^a   Lu, L ^a   Fung, J J ^a   Thomson, A W ^a   Qian, S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FLT3 LIGAND;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED STRAINS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0345471358     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01703-5     Document Type: Conference Paper

References (6)

1. Qian S., Demetris A.J., Murase N., et al. Hepatology. 19:1994;916.
2. Qian S., Lu L., Fu F., et al. Transplantation. 65:1998;1590.
3. Steptoe R.J., Fu F., Li W., et al. J Immunol. 159:1997;5483.
4. van der Merwe P.A., Bodian D.L., Daenke S., et al. J Exp Med. 185:1997;393.
5. Qian S., Lu L., Li Y., et al. J Immunol. 158:1997;4654.
6. Thomson A.W., Lu L., Murase N., et al. Stem Cells. 13:1995;622.